Enerre Pharma Lda listed on Dragonforce ransomware leak site

• Ransomware group: Dragonforce
• Country: Portugal
• Sector: Healthcare
• Announcement date: November 27, 2025

Dragonforce claims data breach against Enerre Pharma Lda

The ransomware group known as Dragonforce has listed the Portuguese pharmaceutical company Enerre Pharma Lda on its dedicated leak site. According to the announcement, the threat actors claim to have successfully exfiltrated a significant volume of data from the organization's systems.

The listing, which appeared on November 27, 2025, serves as a public claim by the group regarding their successful intrusion. This type of announcement is a common tactic used in modern cyberattacks, particularly in models involving double extortion. In such scenarios, threat actors do not merely encrypt an organization's data to disrupt operations but also steal sensitive information to use as leverage, threatening to publish it if a ransom is not paid.

Details of the alleged data theft

The Dragonforce group has made specific claims regarding the scale of the data they have allegedly obtained. According to the group's announcement, they claim to be in possession of approximately 221.1 GB of data belonging to Enerre Pharma Lda. The announcement was published on the same day as the claimed attack date, November 27, 2025.

While the volume of the data has been specified, the group has not provided any specific details regarding the exact content or the specific file types included in the alleged leak. The listing names no specific data types or individual files that have been compromised.

Potential risks and implications

Given that the target organization operates within the healthcare sector, the nature of the data involved is a point of concern. While the specific content remains unconfirmed, the sensitive nature of pharmaceutical and healthcare operations suggests that the data could potentially contain highly confidential information. Such exposure can lead to various secondary risks, including the potential for identity theft or the launch of targeted phishing attacks directed at the company's employees and its various business partners.

About Enerre Pharma Lda

Enerre Pharma Lda is a pharmaceutical and healthcare company based in Portugal. The organization was established upon the foundation and the extensive experience of Enerre Produções e Representações Lda, which possesses over 40 years of industry experience. The company maintains an international presence, providing a range of services including representation and production services within the pharmaceutical sector.

Analysis and organizational impact

This alleged data breach may result in significant negative impacts on the company's commercial reputation and its ability to maintain operational continuity. Because the organization is based in Portugal, the exposure of this data may fall under the regulatory scope of the European Union's General Data Protection Regulation (GDPR), which imposes strict requirements on how personal data is protected and how breaches are reported.

It is important to note that the Dragonforce group is reported to follow a business model where they provide infrastructure to various affiliates. Consequently, there is a possibility that the actual execution of this attack may have been carried out by different actors using the Dragonforce framework. This complexity in ransomware operations makes it difficult for organizations to identify the exact source of a threat.

In response to such incidents, organizations are often required to fulfill specific legal obligations, such as data breach notification requirements to regulatory bodies and the affected parties. To mitigate the risks associated with such threats, organizations in the healthcare sector typically focus on robust defensive measures, including strict access controls, continuous monitoring of network traffic, and comprehensive employee training to recognize social engineering attempts. Maintaining a strong incident response plan is also a critical component of modern cybersecurity posture to manage the fallout of potential data exfiltration.